Oncology and Immuno-Oncology Precision Medicines: From Hit-F

Oncology and Immuno-Oncology Precision Medicines: From Hit-Finding to Pre-Clinical Candidate Selection, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, the featured speakers will shed light on the DRIVE-SM (DRug Integrative discoVEry for Small Molecule) offering, from hit-finding to preclinical models, to assess drug pharmacology in oncology. The presenters will discuss the input of DNA encoding libraries (DEL), development of biostructural techniques and translation of pharmacological tools from in vitro to in vivo. They will also present study cases related to the characterization of specific N-α-Acetyltransferase 50 (Naa50) inhibitors identified using a DNA-encoded library, as well as use of patient-derived xenograft (PDX) cancer models.

Related Keywords

United Kingdom , Barrya Morgan , , Honeycomb Worldwide Inc , Drug Discovery Services , Head Of In Vivo Sciences , Business Unit Service At Oncodesign , Small Molecule , Integrated Drug Discovery , Patient Derived Xenograft , Drug Positioning , Breast Cancer , Chief Scientist Officer , Olivier Duchamp , Vivo Sciences , Business Unit Service , Immuno Oncology Precision Medicines , From Hit Finding , Pre Clinical Candidate , Life Science , ஒன்றுபட்டது கிஂக்டம் , தேன்கூடு உலகளவில் இன்க் , மருந்து கண்டுபிடிப்பு சேவைகள் , சிறிய மூலக்கூறு , ஒருங்கிணைந்த மருந்து கண்டுபிடிப்பு , மருந்து பொஸிஶநிஂக் , மார்பக புற்றுநோய் , தலைமை விஞ்ஞானி அதிகாரி , வணிக அலகு சேவை , வாழ்க்கை அறிவியல் ,